JDRF Canada is launching the $100 Million Campaign to Accelerate, a bold and innovative fundraising effort that aims to accelerate type 1 diabetes research and move beyond insulin
Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes
November 28, 2020 — Ottawa, ON — Canadian Institutes of Health Research
To mark the end of Diabetes Awareness Month, Sonia Sidhu, Member of Parliament for Brampton South, on behalf of the Honourable Patty Hajdu, Minister of Health, announced an investment of $6 million through the CIHR-JDRF Partnership to Defeat Diabetes for two Canadian research teams to accelerate the development of stem cell-based therapies for the treatment of T1D.
JDRF Canada is marking National Diabetes Awareness Month by asking those impacted to write a letter to type 1 diabetes with the launch of their Dear Type 1™ Campaign
Toronto, ON — November 9, 2020 – JDRF Canada, the leading organization funding of type 1 diabetes (T1D) research, is marking National Diabetes Awareness Month (NDAM) by honouring the power and resilience of the T1D community with the “Dear Type 1” campaign.
TORONTO, ON — October 22, 2020 – The Sun Life Ride to Defeat Diabetes for JDRF – a high-energy, corporate fitness event – happening on October 22, will bring together participants from across Canada into the same virtual space for some friendly competition and to raise $1.6 million to help create a world without type 1 diabetes.
Below are significant results linked to the largest annual diabetes congress that just concluded which highlight exciting advances, many of which were enabled by the generous support of our donors, like you.
The JDRF House ParT1D for a Cure presented by Omnipod raises $2.1 million dollars to accelerate research
TORONTO, ON — June 15, 2020 – This past Sunday June 14th, the type 1 diabetes (T1D) community took part in the JDRF House ParT1D for a Cure presented by Omnipod – Canada’s largest virtual house turning type one diabetes into type none. Despite the reality of physical distancing, this new, family-friendly virtual event united Canadians from coast to coast to get loud and raise critical funds for JDRF and its vital T1D research program.
TORONTO, ON — June 11, 2020 – On June 14th, the type 1 diabetes (T1D) community will take part in the JDRF House ParT1D for a Cure presented by Omnipod – Canada’s largest virtual house turning type one diabetes into type none. Despite the reality of physical distancing, this new, family-friendly virtual event will unite Canadians from coast to coast to get loud and raise critical funds for JDRF and its vital T1D research program.
JDRF welcomes announcement from the Government of Canada to better support Canadians with disabilities during COVID-19, including those living with type 1 diabetes
Toronto, ON, June 5, 2020 – JDRF welcomes today’s announcement from the Government of Canada to better support Canadians with disabilities during COVID-19, including those living with type 1 diabetes (T1D). While more details around the program are yet to be released, we do know that a one-time, tax-free payment will be made to all Canadians who currently qualify for the disability tax credit (DTC).
The National Health Service (NHS) in England recently released two studies that provide the first information available about risks of COVID-19 in people with type 1 diabetes (T1D). The findings – which are still undergoing peer review – tell us that for people that need to be hospitalized due to COVID-19, those with type 1 diabetes are at higher risk of death than people with type 2 diabetes, or the general population.
Toronto, ON, May 14, 2020 – Dr. Rangarajan Sambathkumar, a pioneering young investigator at the University Health Network in Toronto, has been awarded a second post-doctoral fellowship ($60,000) for his stem cell research, based on an ongoing collaboration between JDRF Canada and Eli Lilly Canada Inc. (Lilly Canada).
Health Canada’s authorization to use FreeStyle Libre in Hospitals During COVID-19 Pandemic Positive for Canadians with Diabetes
JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, welcomes Health Canada’s authorization under Interim order to use the FreeStyle® Libre System for hospitalized patients during the COVID-19 Pandemic.
The JDRF – Beyond Type 1 Alliance Releases Recommendations for People with Diabetes During COVID-19 Pandemic
The recommendations are supported by 50 international organizations working together to curb the spread of COVID-19 and protect those most vulnerable.